# Cardiovascular Systems Inc

Cardiovascular Systems Inc is a company headquartered in St. Paul, MN, United States.

## Company overview

- **Legal name:** Cardiovascular Systems Inc
- **Former names in filing history:** REPLIDYNE INC (2002-08-12 to 2009-03-03)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** St. Paul, MN, United States
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001180145

## About

Cardiovascular Systems Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001180145, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2022-08-18, it reported annual revenue of USD 236,222,000; net income of USD -36,933,000; total assets of USD 322,677,000 for the fiscal period ended 2022-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-06-30)

- **Revenue:** $236.2M (USD 236,222,000)
- **Net income:** -$36.9M (USD -36,933,000)
- **Total assets:** $322.7M (USD 322,677,000)
- **Cash and equivalents:** $66.4M (USD 66,424,000)
- **Operating cash flow:** -$24.3M (USD -24,272,000)

### FY2021 (period ended 2021-06-30)

- **Revenue:** $259.0M (USD 258,973,000)
- **Net income:** -$13.4M (USD -13,421,000)
- **Total assets:** $352.6M (USD 352,567,000)
- **Cash and equivalents:** $71.1M (USD 71,070,000)
- **Operating cash flow:** -$884,000 (USD -884,000)

### FY2020 (period ended 2020-06-30)

- **Revenue:** $236.5M (USD 236,545,000)
- **Net income:** -$27.2M (USD -27,236,000)
- **Total assets:** $339.5M (USD 339,519,000)
- **Cash and equivalents:** $185.5M (USD 185,463,000)
- **Operating cash flow:** -$12.8M (USD -12,765,000)

### FY2019 (period ended 2019-06-30)

- **Revenue:** $248.0M (USD 248,017,000)
- **Net income:** -$255,000 (USD -255,000)
- **Total assets:** $218.6M (USD 218,577,000)
- **Cash and equivalents:** $74.2M (USD 74,237,000)
- **Operating cash flow:** $10.2M (USD 10,208,000)

## Recent SEC filings

- Form 8-K — filed 2023-04-27 — period 2023-04-27 — FORM 8-K
- Form 8-K — filed 2023-04-13 — period 2023-04-12 — 8-K
- Form 10-Q — filed 2023-02-09 — period 2022-12-31 — 10-Q
- Form 8-K — filed 2023-02-09 — period 2023-02-08 — 8-K
- Form 8-K — filed 2023-02-09 — period 2023-02-08 — 8-K
- Form 8-K — filed 2023-01-03 — period 2022-12-30 — 8-K
- Form 8-K — filed 2022-11-10 — period 2022-11-08 — 8-K
- Form 10-Q — filed 2022-11-03 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-11-03 — period 2022-11-03 — 8-K
- Form DEF 14A — filed 2022-09-28 — period 2022-06-30 — DEF 14A
- Form 10-K — filed 2022-08-18 — period 2022-06-30 — 10-K
- Form 8-K — filed 2022-08-03 — period 2022-08-03 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/cardiovascular-systems-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology